Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / July / Standardizing Myopia Control
Pediatric Refractive Latest News

Standardizing Myopia Control

A new joint position statement urges ophthalmologists and optometrists to standardize contact lens-based myopia control

7/8/2026 2 min read

Share

  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Top Institutions

Clinical Scorecard: Standardizing Myopia Control

At a Glance

CategoryDetail
ConditionMyopia
Key MechanismsProgressive myopia leads to long-term risks including retinal detachment, glaucoma, and irreversible visual impairment.
Target PopulationChildren and young adults, particularly in the Asia-Pacific region.
Care SettingOphthalmology and optometry practices.

Key Highlights

  • Myopia prevalence in some Asia-Pacific countries reaches 95%.
  • Consensus recommendations for myopia control contact lenses include fitting children as young as five.
  • Routine monitoring for contact lenses should occur at three, six, and twelve months.
  • Orthokeratology requires more intensive follow-up than soft lenses.
  • Treatment success benchmarks include refractive progression of no more than 0.50 D annually.

Guideline-Based Recommendations

Diagnosis

  • Assess comfort, vision, centration, and primary gaze lens position during monitoring.

Management

  • Consider treatment discontinuation based on stability in refraction and axial length.

Monitoring & Follow-up

  • Follow-up visits for soft lenses at three, six, and twelve months; for orthokeratology at one day, one month, three months, and six months.

Risks

  • Potential long-term risks of progressive myopia include retinal detachment and irreversible visual impairment.

Patient & Prescribing Data

Children and young adults in the Asia-Pacific region.

Combination therapy with atropine may be used, with a recommended dose range of 0.01-0.05 percent.

Clinical Best Practices

  • Use trial lens fitting as the preferred approach for myopia control soft contact lenses.
  • Employ slit-lamp examination and corneal topography for orthokeratology assessments.
  • Set practical benchmarks for treatment success based on refractive progression and axial length increase.

Related Resources & Content

  • Standardizing Myopia Control Position Statement

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: